| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 09/24/2008 | CN101269121A Method for preparing southern magnolia leaf total flavone and uses thereof |
| 09/24/2008 | CN101269120A Traditional Chinese medicine preparation for treating coronary disease and preparation method thereof |
| 09/24/2008 | CN101269115A Cardiac and cerebral vascular disease treating medicament preparation and method for preparing the same |
| 09/24/2008 | CN101269096A Chinese medicine valid target for treating apoplexy disease |
| 09/24/2008 | CN101269084A Puerarin compound for preventing and treating cardiovascular and cerebrovascular diseases |
| 09/24/2008 | CN101269082A Pharmaceutical combination treating hemorrhoid |
| 09/24/2008 | CN101269079A Emulsion composition comprising prostaglandin E1 |
| 09/24/2008 | CN101269062A Application of loganin in preparing medicament for treating cardiovascular and cerebrovascular diseases |
| 09/24/2008 | CN101269059A Isosorbide dinitrate oral administration impulse pellet preparations |
| 09/24/2008 | CN101269058A Spraying agent containing diclofenac acid and uses thereof |
| 09/24/2008 | CN101269056A Metoprolol salt oral administration impulse pellet preparation |
| 09/24/2008 | CN101269049A Phosphoric acid ligustrazine micropore permeation pump control-release tablet and preparation method thereof |
| 09/24/2008 | CN101269048A Lovastatin sustained-release dropping pill and preparation method thereof |
| 09/24/2008 | CN101269046A Nisoldipine sustained-release dropping pill and preparation method thereof |
| 09/24/2008 | CN101269043A Nicardipine hydrochloride sustained-release dropping pill and preparation method thereof |
| 09/24/2008 | CN101269042A Enalapril maleate sustained-release dropping pill and preparation method thereof |
| 09/24/2008 | CN101269036A Doxazosin mesylate sustained-release dropping pill and preparation method thereof |
| 09/24/2008 | CN101269035A Nicergoline sustained-release dropping pill and preparation method thereof |
| 09/24/2008 | CN101269032A Metoprolol sustained-release dropping pill and preparation method thereof |
| 09/24/2008 | CN101269028A Enalapril sustained-release dropping pill and preparation method thereof |
| 09/24/2008 | CN101269027A Atenolol sustained-release dropping pill and preparation method thereof |
| 09/24/2008 | CN101269021A Puerarin sustained-release dropping pills and preparation method thereof |
| 09/24/2008 | CN101269015A Solid dispersion tablet for treating cardiovascular disease and preparation method thereof |
| 09/24/2008 | CN101268827A Compound Jew's-ear capsule and preparation method thereof |
| 09/24/2008 | CN101268826A Method for producing Chinese caterpillar fungus bacterial filament powder with membrane filtration |
| 09/24/2008 | CN101268792A Xi soy milk |
| 09/24/2008 | CN100420689C Porphyrin derivate with macrosubstituent, preparation process thereof and use as small molecule antioxidant |
| 09/24/2008 | CN100420485C Composition containing active prourokinase, freeze-drying process and freeze-dried preparation thereof |
| 09/24/2008 | CN100420470C Recipe and prepn process of physique strengthening and heart nourishing bolus |
| 09/24/2008 | CN100420454C Pharmaceutical composition for treating apoplexy and preparation method thereof |
| 09/24/2008 | CN100420453C Solid dispersion of extractive of general flavone of Balsamiferou Blumea Herb |
| 09/24/2008 | CN100420383C Health-caring tea made by olive leaf and preparation method thereof |
| 09/23/2008 | US7427681 Anticancer agents; antidiabetic agents; Alzheimer's disease |
| 09/23/2008 | US7427631 especially as inhibitors of MMP12 |
| 09/23/2008 | US7427623 4-Amino-2,3-disubstituted thieno[2,3-d]pyrimidines and pharmacetical compositions thereof |
| 09/23/2008 | US7427616 e.g. 8-(1-methyl-4-phenyl-1H-imidazol-5-yl)-9H-purin-6-amine9-methyl-8-(1-methyl-4-phenyl-1H-imidazol-5-yl)-9H-purin-6-amine; Tie2 receptor tyrosine kinase and angiogenesis inhibitor; diabetic retinopathy, psoriasis, cancer, rheumatoid arthritis, atheroma, Kaposi's sarcoma and haemangioma |
| 09/23/2008 | US7427615 3-substituted-4-pyrimidone derivatives |
| 09/23/2008 | US7427613 7-aryl-3,9-diazabicyclo(3.3.1)non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension, cardiovascular or renal diseases |
| 09/23/2008 | US7427611 4-[(3-aminopropyl) (ethyl)amino]-2-{[1-(carboxymethyl)-2-oxo-2, 3, 4, 5-tetrahydro-1H-1benzazepin-3-yl]amino}carbonyl)-cyclopentyl]methyl}-4-oxobutanoic acid; neutral endopeptidase or human soluble endopeptidase (hSEP) inhibitors; cardiovascular diseases, apoptosis, stroke, neurodegenerative disorder |
| 09/23/2008 | US7427598 Post-natal administration of activity-dependent neurotrophic factor-derived polypeptides for enhancing learning and memory |
| 09/23/2008 | US7427592 Conjugate comprising polypeptide with N-glycosylation site and sugar; increase blood clot formation for treatment of thrombocytopenia and hemophilia |
| 09/23/2008 | US7427397 Vitamin B12 supplement comprising Propionibacterium jensenii 702 together with a delivery agent; tuberculosis |
| 09/23/2008 | CA2480800C Inhibitors of akt activity |
| 09/23/2008 | CA2437820C Endomural therapy |
| 09/23/2008 | CA2432872C Pyrazole compounds useful as protein kinase inhibitors |
| 09/23/2008 | CA2418313C Piperidine derivatives and agent comprising the derivative as active ingredient |
| 09/23/2008 | CA2379747C Novel succinate derivative compounds useful as cysteine protease inhibitors |
| 09/23/2008 | CA2375679C Methods and apparatus for relieving headaches, rhinitis and other common ailments |
| 09/23/2008 | CA2371393C Use of bismuth subgallate in inhibition of production of nitric oxide synthase |
| 09/23/2008 | CA2352915C Pharmaceutical compositions containing mupirocin |
| 09/23/2008 | CA2338256C Bioenhanced formulations comprising eprosartan in oral solid dosage form |
| 09/23/2008 | CA2337825C Disubstituted bicyclic heterocycles, the preparation thereof and their use as pharmaceutical compositions |
| 09/23/2008 | CA2310055C New urethanes, the thio and dithio analogues thereof,the salts thereof, pharmaceutical compositions containing these compounds and their use as well as process for preparing them |
| 09/23/2008 | CA2305183C Postsurgical treatment with dichloroacetate |
| 09/23/2008 | CA2266479C Vitamin d analogues |
| 09/21/2008 | CA2637157A1 Mesenchymal stem cells and uses therefor |
| 09/18/2008 | WO2008112674A1 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
| 09/18/2008 | WO2008112022A1 4-piperidinylurea compounds as soluble epoxide hydrolase inhibitors |
| 09/18/2008 | WO2008111604A1 Novel pyrimidine compound having benzyl(heterocyclicmethyl)amine structure and pharmaceutical product containing the same |
| 09/18/2008 | WO2008111450A1 Sphingosine compound, method for producing the same, and sphingomyelinase inhibitor |
| 09/18/2008 | WO2008111440A1 Method for stable storage of reduced coenzyme q10 |
| 09/18/2008 | WO2008111300A1 Novel diamide derivative |
| 09/18/2008 | WO2008111299A1 Novel diamide derivative |
| 09/18/2008 | WO2008110777A2 Modulators of vegf splicing as pro- and anti-angiogenic agents |
| 09/18/2008 | WO2008110508A1 Pyrrolo-pyridine derivatives for the treatment of disorders associated with inappropriate ikk1 activity |
| 09/18/2008 | WO2008110356A2 Protein pi 16 secreted from the heart and uses thereof |
| 09/18/2008 | WO2008110178A2 MANAGEMENT OF ACUTE CEREBRAL INFARCTION BY SINGLE MEGADOSE OF CLOPIDOGREL (750-1500mg) |
| 09/18/2008 | WO2008110062A1 Compounds with partial agonist activity of pparϝ and application thereof |
| 09/18/2008 | WO2008110008A1 Amide derivatives as calcium channel blockers |
| 09/18/2008 | WO2008109943A1 Phenyl amino pyrimidine compounds and uses thereof |
| 09/18/2008 | WO2008094054A3 6, 8-dichlorchroman-3-yl-l, 3-dihydroimidazole-2-thione derivatives and their use for the treatment of cardiovascular disorders |
| 09/18/2008 | WO2008088849A3 Inflammation treatment, detection and monitoring via trem-1 |
| 09/18/2008 | US20080227954 Therapeutic amino acid sequences for use in treatment and prevention of viral, infectious, cancerous, diabetic, incontinent, hypertensive and nervous system disorders |
| 09/18/2008 | US20080227869 Substituted nitrobenzene derivatives as pharmaceutical and other uses thereof |
| 09/18/2008 | US20080227864 Lhr1 Activators as Medicaments |
| 09/18/2008 | US20080227859 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| 09/18/2008 | US20080227850 Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms |
| 09/18/2008 | US20080227836 Stable Solid Oral Dosage Forms of Valsartan |
| 09/18/2008 | US20080227833 Selective inhibitors of MMP-9 and/or MMP12; antiinflammatory agents for multiple sclerosis and fibrosis; 3R-[2,2-Dimethyl-1 S-(5-phenyl-[1,2,4]oxadiazol-3-yl)-propylcarbamoyl]-2S-hydroxy-5-methyl-hexanohydroxamic acid; bone resorption, metastases, rheumatoid arthritis, Crohn's disease |
| 09/18/2008 | US20080227831 Contains N-methylnicotinamide; seaweed extracts; atherosclerosis |
| 09/18/2008 | US20080227828 Aryl Ureas With Angiogenisis Inhibiting Activity |
| 09/18/2008 | US20080227822 Substituted thienopyrrole carboxylic acid amides, pyrrolothiazole carboxylic acid amides, and related analogs as inhibitors of casein kinase i |
| 09/18/2008 | US20080227789 5-(quinoxalin-2-yl)-N2-(3,4,5-trimethoxyphenyl)thiazole-2,4-diamine; useful in inhibiting the activity of the receptor protein tyrosine kinase Axl; rheumatoid arthritis, vascular disease, vascular injury, psoriasis, visual impairment due to macular degeneration, diabetic retinopathy, retinopathy |
| 09/18/2008 | US20080227780 Soluble epoxide hydrolase inhibitors |
| 09/18/2008 | US20080227778 6-Methoxy-3-(methoxymethyl)-2-methyl-4-phenylisoquinolin-1(2H)-one; treat cardiac arrhythmias |
| 09/18/2008 | US20080227771 Delta d-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it |
| 09/18/2008 | US20080227770 Benzoxazepine Compound |
| 09/18/2008 | US20080227752 Methods to Inhibit Histone Acetyltransferase Using Glycosaminoglycans |
| 09/18/2008 | US20080227747 Composition and methods for treating or preventing degenerative joint and cardiovascular conditions |
| 09/18/2008 | US20080227733 Administering short interfering RNAs (siRNA) which modulates Fas-protein encoding gene expression for inhibiting Fas-protein regulated apoptosis in a cell |
| 09/18/2008 | US20080227728 Therapeutic Agent for the Treatment of a Condition Associated with Peripheral Vascular Disease |
| 09/18/2008 | US20080227713 amino acid sequence of Ser1-Pro2-Lys3-Met4-Val5-Gln6-Gly7-Ser8-Gly9-Cys10-Phe11-Gly12-Arg13-Lys14-Met15-Asp16-Arg17-Ile18-Ser19-Ser20-Ser21-Ser22-Gly23-Leu24-Gly25-Cys26-Lys27-Val28-Leu29-Arg30-Lys31-His32, either Met4, Met15, or both are oxidized; diagnosis heart failure |
| 09/18/2008 | US20080227686 Novel Peptides that Promote Lipid Efflux |
| 09/18/2008 | US20080227135 Autoimmune Conditions and NADPH Oxidase Defects |
| 09/18/2008 | US20080226752 For administration to African-American patients; congestive heart failure; sustained release |
| 09/18/2008 | US20080226732 Nanoparticulate compositions of angiogenesis inhibitors |
| 09/18/2008 | US20080226726 Drug mixture containing biodegradable gel, active materials and stem cells which differentiate into heart tissue in form of patch |
| 09/18/2008 | US20080226646 Use of biomolecular targets in the treatment and visualization of tumors |
| 09/18/2008 | US20080226640 Mixture comprising serum complement system protein (INSP162) use in preparation of vaccines and antibodies for treatment and prevention of infcetion, cell proliferative, skin, neurodegenerative, bone, inflammatory, respiratory system and autoimmune disorders |
| 09/18/2008 | US20080226628 CDR-Grafted Anti-Tissue Factor Antibodies and Methods of Use Thereof |